Published in J Clin Pathol on May 01, 2005
Mutational status of naevus-associated melanomas. Br J Dermatol (2015) 2.68
Melanocytic nevi simulant of melanoma with medicolegal relevance. Virchows Arch (2007) 1.41
c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines. PLoS One (2010) 1.00
NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi. PLoS One (2013) 0.90
Reduced GNG2 expression levels in mouse malignant melanomas and human melanoma cell lines. Am J Cancer Res (2012) 0.87
Management of melanoma families. Cancers (Basel) (2010) 0.76
Expression of Bcl-2, Melan A and HMB-45 in Dysplastic Nevi. Maedica (Buchar) (2016) 0.75
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Cancer statistics, 2000. CA Cancer J Clin (2000) 12.32
hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc Natl Acad Sci U S A (1996) 3.60
A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol (1984) 3.21
Clinical practice. Dysplastic nevi. N Engl J Med (2003) 2.99
Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol (1978) 2.81
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA (1997) 2.65
Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer (1996) 1.71
Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology. Mod Pathol (1989) 1.71
The biologic forms of malignant melanoma. Hum Pathol (1986) 1.51
Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi. J Cutan Pathol (2001) 1.51
p53 Protein expression in nevi and melanomas. Arch Dermatol (1993) 1.44
Cutaneous malignant melanoma and familial dysplastic nevi: evidence for autosomal dominance and pleiotropy. Am J Hum Genet (1986) 1.39
The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. Br J Cancer (1998) 1.15
Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature. Lancet (1980) 1.12
Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res (1993) 1.11
Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody. Histopathology (1991) 1.00
Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol (1983) 0.98
Telomerase activity in melanocytic lesions: A potential marker of tumor biology. Am J Pathol (2000) 0.97
Multiple active junctional naevi with family history of malignant melanoma. Proc R Soc Med (1974) 0.96
How common is the atypical mole syndrome phenotype in apparently sporadic melanoma? J Am Acad Dermatol (1993) 0.92
Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis. Cancer (1988) 0.91
Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Arch Dermatol (1991) 0.90
Abnormal sensitivity to UV-radiation in cultured skin fibroblasts from patients with hereditary cutaneous malignant melanoma and dysplastic nevus syndrome. Int J Cancer (1982) 0.90
A review of hereditary malignant melanoma including biomarkers in familial atypical multiple mole melanoma syndrome. Cancer Genet Cytogenet (1983) 0.88
Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer (1994) 0.88
HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma. Am J Surg Pathol (1989) 0.87
Melanosomal alterations in dysplastic melanocytic nevi. A quantitative, ultrastructural investigation. Cancer (1988) 0.87
Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi, and cutaneous malignant melanomas. Am J Dermatopathol (2001) 0.86
Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus. Biochem Biophys Res Commun (1997) 0.85
Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines. J Invest Dermatol (1983) 0.85
Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline 1-oxide. Proc Natl Acad Sci U S A (1984) 0.84
Bias in the assessment of family history of melanoma and its association with dysplastic nevi in a case-control study. J Clin Epidemiol (1998) 0.83
Loss of heterozygosity detected on 1p and 9q in microdissected atypical nevi. Arch Dermatol (1998) 0.82
Problems with lesions related to the development of malignant melanoma: common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma. Hum Pathol (1998) 0.81
Detection of microsatellite alterations in the spectrum of melanocytic nevi in patients with or without individual or family history of melanoma. Int J Cancer (2000) 0.81
The flow cytometry of melanocytic skin lesions. Br J Cancer (1988) 0.81
Allelic deletion at chromosome 9p21(p16) and 17p13(p53) in microdissected sporadic dysplastic nevus. Hum Pathol (1998) 0.80
Cytogenetics in hereditary malignant melanoma and dysplastic nevus syndrome: is dysplastic nevus syndrome a chromosome instability disorder? Cancer Genet Cytogenet (1987) 0.79
Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study. Arch Dermatol (1994) 0.78
Hypermutability of UV-treated plasmids in dysplastic nevus/familial melanoma cell lines. Cancer Res (1997) 0.77
Utility of a proliferation marker in distinguishing between benign naevocellular naevi and naevocellular naevus-like lesions with malignant properties. Melanoma Res (1995) 0.77
A transmission electron microscopical study of dysplastic naevi. Acta Derm Venereol (1990) 0.77
The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi. Arch Dermatol Res (1990) 0.77
An exchange of ideas about dysplastic nevi and malignant melanomas. Am J Dermatopathol (1985) 0.77
The black cancer--malignant melanoma. Nurs Times (1976) 0.76